Results 161 to 170 of about 21,836 (300)

Echinocandins, New Class of Antifungals, Improving Care of Immunocompromised Cancer Patients

, 2003
Peggy Eastman
openalex   +1 more source

FKS2 Mutations Associated with Decreased Echinocandin Susceptibility of Candida glabrata following Anidulafungin Therapy [PDF]

, 2010
Sofia Costa‐de‐Oliveira, Isabel M. Miranda, Raquel M. Silva, Ana P. Silva, Rita Rocha, António Amorim, Acácio G. Rodrigues, Cidália Pina‐Vaz   +7 more
openalex   +1 more source

In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species [PDF]

, 2010
David R. Andes, Daniel J. Diekema, Michael A. Pfaller, J. Bohrmuller, Karen Marchillo, Alexander J. Lepak   +5 more
openalex   +1 more source

Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance [PDF]

, 2011
Ronen Ben‐Ami, Guillermo García‐Effrón, Russell E. Lewis, Soledad Gamarra, Konstantinos Leventakos, David S. Perlin, Dimitrios P. Kontoyiannis   +6 more
openalex   +1 more source

Central line-associated <i>Cyberlindnera fabianii</i> fungemia: A case report and review of diagnostic and therapeutic challenges. [PDF]

Qatar Med J
Sasi S, Ali GA, Salah H, Goravey W, Maslamani MA.   +4 more
europepmc   +1 more source

Assessing Resistance to the Echinocandin Antifungal Drug Caspofungin in Candida albicans by Profiling Mutations in FKS1

, 2006
Sergey Balashov, Steven Park, David S. Perlin   +2 more
openalex   +1 more source

Echinocandins - first line in invasive candidiasis: how strong is this 'strong' evidence? [PDF]

, 2011
João Gonçalves-Pereira, Pedro Póvoa
openalex   +1 more source

<i>Candida parapsilosis</i> and echinocandins: should the clinical laboratory drop anidulafungin Etest from the susceptibility testing panel? [PDF]

Antimicrob Agents Chemother
Vahedi-Shahandashti R, Moroder E, Lass-Flörl C.   +2 more
europepmc   +1 more source

Candida albicans and Candida glabrata Clinical Isolates Exhibiting Reduced Echinocandin Susceptibility

, 2006
Säntosh K. Katiyar, Michael A. Pfaller, Thomas D. Edlind   +2 more
openalex   +1 more source

An introduction to the future of echinocandin therapy [PDF]

Journal of Antimicrobial Chemotherapy, 2018
openaire   +3 more sources